Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-034685
Filing Date
2026-05-13
Accepted
2026-05-13 17:15:18
Documents
98
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aawh-20260331.htm   iXBRL 10-Q 1270881
2 EX-31.1 exhibit311-03312026.htm EX-31.1 9434
3 EX-31.2 exhibit312-03312026.htm EX-31.2 9211
4 EX-32 exhibit32-03312026.htm EX-32 7443
10 aawh-20260331_g1.jpg GRAPHIC 503544
  Complete submission text file 0001628280-26-034685.txt   10259161

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aawh-20260331.xsd EX-101.SCH 80698
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aawh-20260331_cal.xml EX-101.CAL 94992
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aawh-20260331_def.xml EX-101.DEF 360050
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aawh-20260331_lab.xml EX-101.LAB 906625
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aawh-20260331_pre.xml EX-101.PRE 637207
102 EXTRACTED XBRL INSTANCE DOCUMENT aawh-20260331_htm.xml XML 1229369
Mailing Address 174 NJ-17 ROCHELLE PARK NJ 07662
Business Address 174 NJ-17 ROCHELLE PARK NJ 07662 (646) 661-7600
Ascend Wellness Holdings, Inc. (Filer) CIK: 0001756390 (see all company filings)

EIN.: 830602006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-254800 | Film No.: 26974584
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)